These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17191328)

  • 1. [Hemostasis disorders in severe infections: State of the art].
    Fourrier F
    Med Mal Infect; 2006 Oct; 36(10):524-533. PubMed ID: 17191328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostasis disorders in severe infections: state of the art].
    Fourrier F
    Med Mal Infect; 2006 Jun; 36(6):304-13. PubMed ID: 16713162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation inhibitors in severe sepsis: state of the art].
    Fourrier F
    Rev Med Interne; 2003 May; 24(5):295-304. PubMed ID: 12763175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemostatic disorders in liver disease].
    Mitrică D; Drug VL; Prelipcean CC; Stan M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):313-20. PubMed ID: 19294997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin.
    Al Otair HA; Abdel Gader AG; Khurshid SM; Alzeer AH; Al Momen AK; Al Shaikh M; Al Gahtani F; Al Aseri ZA; Abdelrazik HA
    Turk J Haematol; 2016 Jun; 33(2):112-8. PubMed ID: 26377606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic modulation of coagulation in sepsis].
    Loew A; Riess H
    Hamostaseologie; 2005 May; 25(2):191-9. PubMed ID: 15924157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome.
    Albert V; Arulselvi S; Agrawal D; Pati HP; Pandey RM
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):32-43. PubMed ID: 30291825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation inhibitor replacement during sepsis: useless?
    Hoffman JN; Faist E
    Crit Care Med; 2000 Sep; 28(9 Suppl):S74-6. PubMed ID: 11007203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?
    Boldt J; Papsdorf M; Rothe A; Kumle B; Piper S
    Crit Care Med; 2000 Feb; 28(2):445-50. PubMed ID: 10708181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation abnormalities in sepsis.
    Tsao CM; Ho ST; Wu CC
    Acta Anaesthesiol Taiwan; 2015 Mar; 53(1):16-22. PubMed ID: 25544351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemostatic disorders: clinical management based on molecular mechanisms].
    Scharf RE
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):171-85; quiz 186-8. PubMed ID: 21394708
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin improves sepsis-induced coagulopathy: A retrospective, single-center observational study.
    Ishikura H; Nakamura Y; Kawano Y; Tanaka J; Mizunuma M; Ohta D; Nishida T; Murai A
    J Crit Care; 2015 Jun; 30(3):579-83. PubMed ID: 25776897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of haemostasis and coagulation].
    Darnige L; Fischer AM
    Rev Prat; 2013 May; 63(5):699-708. PubMed ID: 23789502
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress towards overcoming coagulopathy and hemostatic dysfunction associated with xenotransplantation.
    Cowan PJ; Robson SC
    Int J Surg; 2015 Nov; 23(Pt B):296-300. PubMed ID: 26220018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of blood coagulation inhibitors in colon cancer].
    Sierko E; Zawadzki RJ; Zimnoch L; Sulkowski S; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2006 Apr; 20(118):462-7. PubMed ID: 16886577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation inhibitor substitution during sepsis.
    Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
    Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interpretation of hemostatic and fibrinolytic markers].
    Asakura H
    Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
    Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu I; Ersoz HO
    Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.